Hyuna S, Jacques F, Rebecca LS, Mathieu L, Isabelle S, Ahmedin J, Freddie B. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209.
Ally A, Balasundaram M, Carlsen R, Chuah E, Clarke A, Dhalla N, Holt RA, Jones S, Lee D, Ma Y, et al. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell. 2017;169:1327–1341.e1323.
Hlady RA, Robertson KD. Genetic and epigenetic heterogeneity in normal liver homeostasis and its implications for liver disease and hepatocellular cancer. Semin Liver Dis. 2018;38:41–50.
Llovet JM, Montal R, Sia D, Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 2018;15:599–616.
Sohum M, Jin Z. Liquid-liquid phase separation drives cellular function and dysfunction in cancer. Nat Rev Cancer. 2022;22:239–52.
Jeong-Mo C, Alex SH, Rohit VP. Physical principles underlying the complex biology of intracellular phase transitions. Annu Rev Biophys. 2020;49:107.
Hnisz D, Shrinivas K, Young R, Chakraborty A, Sharp P. A phase separation model for transcriptional control. Cell. 2017;169:13–23.
CAS PubMed PubMed Central Google Scholar
Bouchard J, Otero J, Scott D, Szulc E, Martin E, Sabri N, Granata D, Marzahn M, Lindorff-Larsen K, Salvatella X, et al. Cancer mutations of the tumor suppressor SPOP disrupt the formation of active. Phase-Separated Compartments Molecular cell. 2018;72:19-36.e18.
Trojanowski J, Frank L, Rademacher A, Mücke N, Grigaitis P, Rippe K. Transcription activation is enhanced by multivalent interactions independent of phase separation. Mol Cell. 2022;82:1878-1893.e1810.
Boija A, Klein I, Sabari B, Dall’Agnese A, Coffey E, Zamudio A, Li C, Shrinivas K, Manteiga J, Hannett N, et al. Transcription factors activate genes through the phase-separation capacity of their activation domains. Cell. 2018;175:1842-1855.e1816.
Zhang H, Shao S, Zeng Y, Wang X, Qin Y, Ren Q, Xiang S, Wang Y, Xiao J, Sun Y. Reversible phase separation of HSF1 is required for an acute transcriptional response during heat shock. Nat Cell Biol. 2022;24:340–52.
Liu J, Chen Y, Nong B, Luo X, Cui K, Li Z, Zhang P, Tan W, Yang Y, Ma W, et al. CRISPR-assisted transcription activation by phase-separation proteins. Protein Cell. 2023;14:874–87.
CAS PubMed PubMed Central Google Scholar
Liu Q, Li J, Zhang W, Xiao C, Zhang S, Nian C, Li J, Su D, Chen L, Zhao Q, et al. Glycogen accumulation and phase separation drives liver tumor initiation. Cell. 2021;184:5559-5576.e5519.
Laoukili J, Kooistra MR, Brás A, Kauw J, Kerkhoven RM, Morrison A, Clevers H, Medema RH. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol. 2005;7:126–36.
Hannenhalli S, Kaestner KH. The evolution of Fox genes and their role in development and disease. Nat Rev Genet. 2009;10:233–40.
CAS PubMed PubMed Central Google Scholar
Bella L, Zona S, Nestal de Moraes G, Lam EW. FOXM1: a key oncofoetal transcription factor in health and disease. Semin Cancer Biol. 2014;29:32–9.
Weiler SME, Pinna F, Wolf T, Lutz T, Geldiyev A, Sticht C, Knaub M, Thomann S, Bissinger M, Wan S, et al. Induction of chromosome instability by activation of yes-associated protein and forkhead box M1 in liver cancer. Gastroenterology. 2017;152:2037-2051.e2022.
Chai N, Xie HH, Yin JP, Sa KD, Guo Y, Wang M, Liu J, Zhang XF, Zhang X, Yin H, et al. FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1. Biochem Biophys Res Commun. 2018;500:924–9.
Liu J, Li J, Wang K, Liu H, Sun J, Zhao X, Yu Y, Qiao Y, Wu Y, Zhang X, et al. Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers. Signal Transduct Target Ther. 2021;6:42.
CAS PubMed PubMed Central Google Scholar
Bond J, Roberts E, Mochida GH, Hampshire DJ, Scott S, Askham JM, Springell K, Mahadevan M, Crow YJ, Markham AF, et al. ASPM is a major determinant of cerebral cortical size. Nat Genet. 2002;32:316–20.
Bond J, Scott S, Hampshire D, Springell K, Corry P, Abramowicz M, Mochida G, Hennekam R, Maher E, Fryns J, et al. Protein-truncating mutations in ASPM cause variable reduction in brain size. Am J Hum Genet. 2003;73:1170–7.
CAS PubMed PubMed Central Google Scholar
Wu X, Xu S, Wang P, Wang ZQ, Chen H, Xu X, Peng B. ASPM promotes ATR-CHK1 activation and stabilizes stalled replication forks in response to replication stress. Proc Natl Acad Sci U S A. 2022;119: e2203783119.
CAS PubMed PubMed Central Google Scholar
Lin S, Pan H, Liu S, Jeng Y, Hu F, Peng S, Lai P, Hsu H. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res. 2008;14:4814–20.
Hsu CC, Liao WY, Chang KY, Chan TS, Huang PJ, Chiang CT, Shan YS, Cheng LH, Liao TY, Tsai KK. A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer. Gastric Cancer. 2021;24:624–39.
Wang WY, Hsu CC, Wang TY, Li CR, Hou YC, Chu JM, Lee CT, Liu MS, Su JJ, Jian KY, et al. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression. Gastroenterology. 2013;145:1110–20.
Pai VC, Hsu CC, Chan TS, Liao WY, Chuu CP, Chen WY, Li CR, Lin CY, Huang SP, Chen LT, Tsai KK. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling. Oncogene. 2019;38:1340–53.
Zeng WJ, Cheng Q, Wen ZP, Wang JY, Chen YH, Zhao J, Gong ZC, Chen XP. Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas. J Cell Mol Med. 2020;24:9613–26.
CAS PubMed PubMed Central Google Scholar
Hsu CC, Liao WY, Chan TS, Chen WY, Lee CT, Shan YS, Huang PJ, Hou YC, Li CR, Tsai KK. The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis. J Pathol. 2019;249:498–508.
CAS PubMed PubMed Central Google Scholar
Liao WY, Hsu CC, Chan TS, Yen CJ, Chen WY, Pan HW, Tsai KK. Dishevelled 1-regulated superpotent cancer stem cells mediate Wnt heterogeneity and tumor progression in hepatocellular carcinoma. Stem Cell Rep. 2020;14:462–77.
Bernhofer M, Goldberg T, Wolf S, Ahmed M, Zaugg J, Boden M, Rost B. NLSdb-major update for database of nuclear localization signals and nuclear export signals. Nucleic Acids Res. 2018;46:D503-d508.
Fu Z, Malureanu L, Huang J, Wang W, Li H, van Deursen J, Tindall D, Chen J. Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat Cell Biol. 2008;10:1076–82.
CAS PubMed PubMed Central Google Scholar
Anders L, Ke N, Hydbring P, Choi Y, Widlund H, Chick J, Zhai H, Vidal M, Gygi S, Braun P, Sicinski P. A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell. 2011;20:620–34.
CAS PubMed PubMed Central Google Scholar
Lafontaine D, Riback J, Bascetin R, Brangwynne C. The nucleolus as a multiphase liquid condensate. Nat Rev Mol Cell Biol. 2021;22:165–82.
Ahn J, Davis E, Daugird T, Zhao S, Quiroga I, Uryu H, Li J, Storey A, Tsai Y, Keeley D, et al. Phase separation drives aberrant chromatin looping and cancer development. Nature. 2021;595:591–5.
CAS PubMed PubMed Central Google Scholar
Xie Z, Janczyk P, Zhang Y, Liu A, Shi X, Singh S, Facemire L, Kubow K, Li Z, Jia Y, et al. A cytoskeleton regulator AVIL drives tumorigenesis in glioblastoma. Nat Commun. 2020;11:3457.
CAS PubMed PubMed Central Google Scholar
Chen Z, Hou C, Wang L, Yu C, Chen T, Shen B, Hou Y, Li P, Li T. Screening membraneless organelle participants with machine-learning models that integrate multimodal features. Proc Natl Acad Sci USA. 2022;119: e2115369119.
Comments (0)